STAT News

STAT+: What’s the deal with Isomorphic Labs?

In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care.

By STAT News

1 min read
STAT+: What’s the deal with Isomorphic Labs?
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights